ZERO PROSTATE CANCER — Lobbying Disclosure | Poliscope

ZERO PROSTATE CANCER

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Spend

$5.4M

Filings

116

Firms Hired

Active Period

1999–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	$467,222	3	1
2025	$490,000	4	1
2024	$410,000	4	1
2023	$440,000	4	1
2022	$475,000	4	1
2021	$354,841	4	1
2020	$303,319	4	1
2019	$160,000	4	1
2018	$160,000	4	1
2017	$386,800	5	1
2016	$267,073	4	1
2015	$173,400	6	1
2014	$90,000	6	1
2013	$60,000	4	1
2012	$60,000	7	1
2011	$75,000	5	1
2010	$105,000	8	1
2009	$60,000	4	1
2008	$75,000	8	1
2007	$120,000	6	1
2006	$40,000	1	1
2005	$80,000	3	1
2004	$160,000	4	1
2003	$120,000	3	1
2002	$40,000	1	1
2001	$80,000	2	1
2000	$65,000	2	1
1999	$80,000	2	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
ZERO PROSTATE CANCER	$5,397,655	116

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	103
SENATE	103
Veterans Affairs, Dept of (VA)	26
Defense, Dept of (DOD)	16
Natl Institutes of Health (NIH)	16
Health & Human Services, Dept of (HHS)	15
Centers For Medicare and Medicaid Services (CMS)	13
Executive Office of the President (EOP)	10
White House Office	9
Centers For Disease Control & Prevention (CDC)	8
Food & Drug Administration (FDA)	6
Health Resources & Services Administration (HRSA)	5
President of the U.S.	2
U.S. Postal Service (USPS)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	91
Budget/Appropriations	Budget/Appropriations	89
Insurance	Insurance	42
Veterans	Veterans	25
Medicare/Medicaid	Medicare/Medicaid	17
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	14
Postal	Postal	5
Defense	Defense	4

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1300119th Congress

PSA Screening for HIM Act

2026 · third_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening

Client expense: $123,567 · Firm income: —

Matched citations: HR 1300

H.R. 1300119th Congress

PSA Screening for HIM Act

2026 · third_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening Extension of enhanced Advance Premium Tax Credits for Marketplace plans HR 7602 State of Mens Health Act - creating an Office of Men's Health at HHS

Client expense: $123,567 · Firm income: —

Matched citations: HR 1300

H.R. 5883119th Congress

Safer Supervision Act of 2025

2026 · third_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 5883 - POPCaP Authorization Act - VA Precision Oncology Program for Cancer of the Prostate

Client expense: $123,567 · Firm income: —

Matched citations: HR 5883

H.R. 7602119th Congress

State of Men’s Health Act

2026 · third_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening Extension of enhanced Advance Premium Tax Credits for Marketplace plans HR 7602 State of Mens Health Act - creating an Office of Men's Health at HHS

Client expense: $123,567 · Firm income: —

Matched citations: HR 7602

Show 21 more cited filings

S. 293119th Congress

WALL Act of 2025

2026 · third_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening

Client expense: $123,567 · Firm income: —

Matched citations: S 293

S. 293119th Congress

WALL Act of 2025

2026 · third_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening Extension of enhanced Advance Premium Tax Credits for Marketplace plans HR 7602 State of Mens Health Act - creating an Office of Men's Health at HHS

Client expense: $123,567 · Firm income: —

Matched citations: S 293

H.R. 1300119th Congress

PSA Screening for HIM Act

2026 · second_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening

Client expense: $123,655 · Firm income: —

Matched citations: HR 1300

H.R. 1300119th Congress

PSA Screening for HIM Act

2026 · second_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening Extension of enhanced Advance Premium Tax Credits for Marketplace plans HR 7602 State of Mens Health Act - creating an Office of Men's Health at HHS

Client expense: $123,655 · Firm income: —

Matched citations: HR 1300

H.R. 5883119th Congress

Safer Supervision Act of 2025

2026 · second_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 5883 - POPCaP Authorization Act - VA Precision Oncology Program for Cancer of the Prostate

Client expense: $123,655 · Firm income: —

Matched citations: HR 5883

H.R. 7602119th Congress

State of Men’s Health Act

2026 · second_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening Extension of enhanced Advance Premium Tax Credits for Marketplace plans HR 7602 State of Mens Health Act - creating an Office of Men's Health at HHS

Client expense: $123,655 · Firm income: —

Matched citations: HR 7602

S. 293119th Congress

WALL Act of 2025

2026 · second_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening Extension of enhanced Advance Premium Tax Credits for Marketplace plans HR 7602 State of Mens Health Act - creating an Office of Men's Health at HHS

Client expense: $123,655 · Firm income: —

Matched citations: S 293

S. 293119th Congress

WALL Act of 2025

2026 · second_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening

Client expense: $123,655 · Firm income: —

Matched citations: S 293

H.R. 1300119th Congress

PSA Screening for HIM Act

2026 · first_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening Extension of enhanced Advance Premium Tax Credits for Marketplace plans HR 7602 State of Mens Health Act - creating an Office of Men's Health at HHS

Client expense: $220,000 · Firm income: —

Matched citations: HR 1300

H.R. 1300119th Congress

PSA Screening for HIM Act

2026 · first_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening, extension of enhanced Advance Premium Tax Credits for Marketplace plans

Client expense: $220,000 · Firm income: —

Matched citations: HR 1300

H.R. 7602119th Congress

State of Men’s Health Act

2026 · first_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening Extension of enhanced Advance Premium Tax Credits for Marketplace plans HR 7602 State of Mens Health Act - creating an Office of Men's Health at HHS

Client expense: $220,000 · Firm income: —

Matched citations: HR 7602

S. 293119th Congress

WALL Act of 2025

2026 · first_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening Extension of enhanced Advance Premium Tax Credits for Marketplace plans HR 7602 State of Mens Health Act - creating an Office of Men's Health at HHS

Client expense: $220,000 · Firm income: —

Matched citations: S 293

S. 293119th Congress

WALL Act of 2025

2026 · first_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening, extension of enhanced Advance Premium Tax Credits for Marketplace plans

Client expense: $220,000 · Firm income: —

Matched citations: S 293

H.R. 1300119th Congress

PSA Screening for HIM Act

2025 · fourth_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening Extension of enhanced Advance Premium Tax Credits for Marketplace plans

Client expense: $130,000 · Firm income: —

Matched citations: HR 1300

H.R. 1300119th Congress

PSA Screening for HIM Act

2025 · fourth_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening, extension of enhanced Advance Premium Tax Credits for Marketplace plans

Client expense: $130,000 · Firm income: —

Matched citations: HR 1300

S. 293119th Congress

WALL Act of 2025

2025 · fourth_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening, extension of enhanced Advance Premium Tax Credits for Marketplace plans

Client expense: $130,000 · Firm income: —

Matched citations: S 293

S. 293119th Congress

WALL Act of 2025

2025 · fourth_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening Extension of enhanced Advance Premium Tax Credits for Marketplace plans

Client expense: $130,000 · Firm income: —

Matched citations: S 293

H.R. 1300119th Congress

PSA Screening for HIM Act

2025 · third_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening

Client expense: $130,000 · Firm income: —

Matched citations: HR 1300

H.R. 1300119th Congress

PSA Screening for HIM Act

2025 · third_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening, extension of enhanced Advance Premium Tax Credits for Marketplace plans

Client expense: $130,000 · Firm income: —

Matched citations: HR 1300

S. 293119th Congress

WALL Act of 2025

2025 · third_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening, extension of enhanced Advance Premium Tax Credits for Marketplace plans

Client expense: $130,000 · Firm income: —

Matched citations: S 293

S. 293119th Congress

WALL Act of 2025

2025 · third_quarter · Firm: ZERO PROSTATE CANCER

Open original LDA filing ↗

Cited source text and reported amounts

HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening

Client expense: $130,000 · Firm income: —

Matched citations: S 293

Source: Senate LDA